|Slideshows|December 11, 2019

7 Trends in Digital Mental Health for 2020

It has been a busy year for digital mental health. While no one knows what 2020 will bring, some themes are sure to continue to shape the field.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

ByJoseph F. Goldberg, MD,Roy Perlis, MD

June 10th 2026

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

ByLeah Kuntz

June 8th 2026

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research

ByMark Gerstein, PhD

June 5th 2026

Harm Reduction for Behavioral Addiction in the Digital Age

ByHector A. Colon-Rivera, MD, MBA, MRO, FAPA

May 21st 2026

The New Plan to Protect Youth Online: Surgeon General’s Warning on Harms of Screen Use

ByLeah Kuntz

May 21st 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

7 Trends in Digital Mental Health for 2020

Related Content

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research

Harm Reduction for Behavioral Addiction in the Digital Age

The New Plan to Protect Youth Online: Surgeon General’s Warning on Harms of Screen Use

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

Monoamines: A Full House

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings